Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients

J Cardiovasc Dis Res. 2011 Jul;2(3):153-5. doi: 10.4103/0975-3583.85261.

Abstract

Sleep disorders are the common side effects of beta blockers. Beta blockers have been shown to reduce the production of melatonin via specific inhibition of adrenergic beta1-receptors. Exogenous melatonin, taken in the evening as a supplement, could reduce the central nervous system (CNS) side effects (sleep disorder) associated with beta-adrenergic receptor blockers as well as the potential risk associated with reduction of the melatonin synthesis.

Keywords: Beta blockers; hypertension; melatonin.